248 related articles for article (PubMed ID: 36295691)
21. Therapeutic effects of the long-term use of PAN membrane dialyzer in hemodialysis patients: efficacy in old dialysis patients with mild PAD.
Nakada H; Kashiwagi T; Iino Y; Katayama Y
J Nippon Med Sch; 2014; 81(4):221-35. PubMed ID: 25186576
[TBL] [Abstract][Full Text] [Related]
22. A New Polysulfone Membrane Dialyzer, NV, with Low-Fouling and Antithrombotic Properties.
Oshihara W; Ueno Y; Fujieda H
Contrib Nephrol; 2017; 189():222-229. PubMed ID: 27951572
[TBL] [Abstract][Full Text] [Related]
23. Analytical and Finite Element Modeling of Nanomembranes for Miniaturized, Continuous Hemodialysis.
Burgin T; Johnson D; Chung H; Clark A; McGrath J
Membranes (Basel); 2015 Dec; 6(1):. PubMed ID: 26729179
[TBL] [Abstract][Full Text] [Related]
24. Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis.
Fiorentino M; La Fergola F; De Rosa S
J Nephrol; 2024 Jan; 37(1):23-37. PubMed ID: 37843731
[TBL] [Abstract][Full Text] [Related]
25. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
26. Radionuclide method for evaluating the performance of hemodialysis in vivo.
Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
[TBL] [Abstract][Full Text] [Related]
27. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
[TBL] [Abstract][Full Text] [Related]
28. Polyvinylpyrrolidone in hemodialysis membranes: Impact on platelet loss during hemodialysis.
Zawada AM; Melchior P; Erlenkötter A; Delinski D; Stauss-Grabo M; Kennedy JP
Hemodial Int; 2021 Oct; 25(4):498-506. PubMed ID: 34085391
[TBL] [Abstract][Full Text] [Related]
29. Development of dialyzer with immobilized glycoconjugate polymers for removal of Shiga-toxin.
Miyagawa A; Watanabe M; Igai K; Kasuya MC; Natori Y; Nishikawa K; Hatanaka K
Biomaterials; 2006 Jun; 27(17):3304-11. PubMed ID: 16499963
[TBL] [Abstract][Full Text] [Related]
30. Second Generation Nanoporous Silicon Nitride Membranes for High Toxin Clearance and Small Format Hemodialysis.
Hill K; Walker SN; Salminen A; Chung HL; Li X; Ezzat B; Miller JJ; DesOrmeaux JS; Zhang J; Hayden A; Burgin T; Piraino L; May MN; Gaborski TR; Roussie JA; Taylor J; DiVincenti L; Shestopalov AA; McGrath JL; Johnson DG
Adv Healthc Mater; 2020 Feb; 9(4):e1900750. PubMed ID: 31943849
[TBL] [Abstract][Full Text] [Related]
31. The past, present and future of the dialyzer.
Mineshima M
Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
[TBL] [Abstract][Full Text] [Related]
32. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
[TBL] [Abstract][Full Text] [Related]
33. Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.
Florens N; Guebre-Egziabher F; Juillard L
J Nephrol; 2022 Jan; 35(1):33-41. PubMed ID: 33837932
[TBL] [Abstract][Full Text] [Related]
34. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
Geremia I; Bansal R; Stamatialis D
Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
[TBL] [Abstract][Full Text] [Related]
35. In vitro clearance and hemocompatibility assessment of ultrathin nanoporous silicon membranes for hemodialysis applications using human whole blood.
Ahmadi M; Gorbet M; Yeow JT
Blood Purif; 2013; 35(4):305-13. PubMed ID: 23920150
[TBL] [Abstract][Full Text] [Related]
36. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
37. In vitro hemocompatibility of PVA-alginate ester as a candidate for hemodialysis membrane.
Amri C; Mudasir M; Siswanta D; Roto R
Int J Biol Macromol; 2016 Jan; 82():48-53. PubMed ID: 26459169
[TBL] [Abstract][Full Text] [Related]
38. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
39. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
[TBL] [Abstract][Full Text] [Related]
40. Influence of blood flow on adsorption of beta2-microglobulin onto AN69 dialyzer membrane.
Kandus A; Malovrh M; Bren AF
Artif Organs; 1997 Aug; 21(8):903-6. PubMed ID: 9247179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
